Three studies presented at SfN Neuroscience 2019 have shed light on the complex interplay between microglia in neuroinflammation and disease pathology in mice.
Three studies presented at SfN Neuroscience 2019 reveal advancements in autism research that could improve intervention and treatment.
Four studies presented at SfN Neuroscience have demonstrated how the microbiome interacts with the brain in mice, revealing the possible mechanisms behind gut–brain communication.
Abstracts presented at SfN Neuroscience 2019 provide insight into how gene therapy advancements could be used treat diseases such as Parkinson’s and Alzheimer’s in the future.
Abstracts presented at SfN Neuroscience 2019 have revealed that metabolic disturbances in the brain could exacerbate and forewarn Alzheimer’s pathology in mice.
A recent study on the relationship between the huntingtin mutation and astrocytes has revealed that inhibition of the mutation in the glial cells could stop disease progression.
A low-cost and widely available drug, termed tranexamic acid, could reduce deaths from traumatic brain injury by ‘hundreds of thousands’, according to a recent study.
Researchers have suggested that traumatic microbleeds may be a form of injury to brain blood vessels that could predict worse outcomes following a head injury.
A recently published study has indicated that eliminating microglia could significantly reduce tau-linked brain damage in mice, providing a path for novel treatments.
Researchers have discovered that more women and less men are diagnosed with amnestic mild cognitive impairment when sex-specific scores are used.